HIPK2 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "HIPK2" in English language version.

refsWebsite

Global rank English rank

46nih.gov

4^th place

29doi.org

2^nd place

4harvard.edu

18^th place

17^th place

3semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1uniprot.org

5,673^rd place

6,418^th place

1expasy.org

7,021^st place

7,383^rd place

1web.archive.org

1^st place

1handle.net

102^nd place

76^th place

1ist.ac.at

low place

1ahajournals.org

3,608^th place

6,526^th place

1worldcat.org

5^th place

ahajournals.org (Global: 3,608^th place; English: 6,526^th place)

circ.ahajournals.org

Guo Y, Sui J, Zhang Q, Barnett J, Force T, Lal H (2017-11-14). "Abstract 18728: Loss of Homeodomain-Interacting Protein Kinase 2 in Cardiomyocytes Leads to Cardiac Dysfunction". Circulation. 136 (Suppl 1): A18728. ISSN 0009-7322.

doi.org (Global: 2^nd place; English: 2^nd place)

Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, Debatin K, Hug H (March 2001). "Isolation and characterization of cDNAs for the protein kinase HIPK2". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1518 (1–2): 168–72. doi:10.1016/S0167-4781(00)00308-0. PMID 11267674.
Sung KS, Go YY, Ahn JH, Kim YH, Kim Y, Choi CY (June 2005). "Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation". FEBS Letters. 579 (14): 3001–8. doi:10.1016/j.febslet.2005.04.053. PMID 15896780. S2CID 37551460.
Hofmann TG, Mincheva A, Lichter P, Dröge W, Schmitz ML (2000). "Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34". Biochimie. 82 (12): 1123–7. doi:10.1016/S0300-9084(00)01196-2. PMID 11120354.
Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y (October 1998). "Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors". The Journal of Biological Chemistry. 273 (40): 25875–9. doi:10.1074/jbc.273.40.25875. PMID 9748262.
Pierantoni GM, Bulfone A, Pentimalli F, Fedele M, Iuliano R, Santoro M, Chiariotti L, Ballabio A, Fusco A (January 2002). "The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues". Biochemical and Biophysical Research Communications. 290 (3): 942–7. doi:10.1006/bbrc.2001.6310. PMID 11798164.
Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, Debatin K, Hug H (2001). "Isolation and characterization of cDNAs for the protein kinase HIPK2". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1518 (1–2): 168–72. doi:10.1016/S0167-4781(00)00308-0. PMID 11267674. The nucleotide sequence data have been deposited in GenBank under the accession numbers AF208291 and AF208292, respectively
Kim YH, Choi CY, Kim Y (October 1999). "Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1". Proceedings of the National Academy of Sciences of the United States of America. 96 (22): 12350–5. Bibcode:1999PNAS...9612350K. doi:10.1073/pnas.96.22.12350. PMC 22920. PMID 10535925.
Sung KS, Lee YA, Kim ET, Lee SR, Ahn JH, Choi CY (April 2011). "Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53". Experimental Cell Research. 317 (7): 1060–70. doi:10.1016/j.yexcr.2010.12.016. PMID 21192925.
Sombroek D, Hofmann TG (February 2009). "How cells switch HIPK2 on and off". Cell Death and Differentiation. 16 (2): 187–94. doi:10.1038/cdd.2008.154. PMID 18974774.
Zhang D, Li K, Erickson-Miller CL, Weiss M, Wojchowski DM (January 2005). "DYRK gene structure and erythroid-restricted features of DYRK3 gene expression". Genomics. 85 (1): 117–30. doi:10.1016/j.ygeno.2004.08.021. PMID 15607427.
Feng Y, Zhou L, Sun X, Li Q (March 2017). "Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies". Oncotarget. 8 (12): 20452–20461. doi:10.18632/oncotarget.14723. PMC 5386776. PMID 28107201.
Kuwano Y, Nishida K, Akaike Y, Kurokawa K, Nishikawa T, Masuda K, Rokutan K (September 2016). "Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome". International Journal of Molecular Sciences. 17 (10): 1638. doi:10.3390/ijms17101638. PMC 5085671. PMID 27689990.
de la Vega L, Fröbius K, Moreno R, Calzado MA, Geng H, Schmitz ML (February 2011). "Control of nuclear HIPK2 localization and function by a SUMO interaction motif". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813 (2): 283–97. doi:10.1016/j.bbamcr.2010.11.022. PMID 21145359.
Kim EJ, Park JS, Um SJ (August 2002). "Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo". The Journal of Biological Chemistry. 277 (35): 32020–8. doi:10.1074/jbc.M200153200. PMID 11925430.
Puca R, Nardinocchi L, Givol D, D'Orazi G (August 2010). "Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells". Oncogene. 29 (31): 4378–87. doi:10.1038/onc.2010.183. PMID 20514025.
Puca R, Nardinocchi L, Bossi G, Sacchi A, Rechavi G, Givol D, D'Orazi G (January 2009). "Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc". Experimental Cell Research. 315 (1): 67–75. doi:10.1016/j.yexcr.2008.10.018. PMID 18996371.
Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH (October 2003). "Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP". Cell. 115 (2): 177–86. doi:10.1016/S0092-8674(03)00802-X. PMID 14567915. S2CID 17430200.
de la Vega L, Grishina I, Moreno R, Krüger M, Braun T, Schmitz ML (May 2012). "A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress". Molecular Cell. 46 (4): 472–83. doi:10.1016/j.molcel.2012.03.003. PMID 22503103.
Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG (July 2008). "Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR". Nature Cell Biology. 10 (7): 812–24. doi:10.1038/ncb1743. PMID 18536714. S2CID 7668614.
Choi JR, Lee SY, Shin KS, Choi CY, Kang SJ (November 2017). "p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function". Scientific Reports. 7 (1): 16136. Bibcode:2017NatSR...716136C. doi:10.1038/s41598-017-16489-w. PMC 5701035. PMID 29170424.
Wook Choi D, Yong Choi C (2014-10-29). "HIPK2 modification code for cell death and survival". Molecular & Cellular Oncology. 1 (2) e955999. doi:10.1080/23723548.2014.955999. PMC 4905192. PMID 27308327.
Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S (March 2007). "MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis". Molecular Cell. 25 (5): 739–50. doi:10.1016/j.molcel.2007.02.008. PMID 17349959.
MacLachlan TK, El-Deiry WS (July 2002). "Apoptotic threshold is lowered by p53 transactivation of caspase-6". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9492–7. Bibcode:2002PNAS...99.9492M. doi:10.1073/pnas.132241599. PMC 123168. PMID 12089322.
Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, Aikawa Y, Kimura A, Kitabayashi I (November 2007). "Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription". Oncogene. 26 (51): 7231–9. doi:10.1038/sj.onc.1210523. PMID 17533375.
Kovács KA, Steinmann M, Halfon O, Magistretti PJ, Cardinaux JR (November 2015). "Complex regulation of CREB-binding protein by homeodomain-interacting protein kinase 2" (PDF). Cellular Signalling. 27 (11): 2252–60. doi:10.1016/j.cellsig.2015.08.001. hdl:10754/594104. PMID 26247811. Archived from the original (PDF) on 2018-07-21. Retrieved 2019-07-08.
Harada J, Kokura K, Kanei-Ishii C, Nomura T, Khan MM, Kim Y, Ishii S (October 2003). "Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation". The Journal of Biological Chemistry. 278 (40): 38998–9005. doi:10.1074/jbc.M307112200. PMID 12874272.
Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, Dusetti NJ (September 2003). "TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity". The Journal of Biological Chemistry. 278 (39): 37722–9. doi:10.1074/jbc.M301979200. PMID 12851404.
Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, Govoni S, D'Orazi G, Racchi M (April 2010). "Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival". PLOS ONE. 5 (4) e10171. Bibcode:2010PLoSO...510171L. doi:10.1371/journal.pone.0010171. PMC 2854690. PMID 20418953.
Fan Y, Wang N, Chuang P, He JC (November 2014). "Role of HIPK2 in kidney fibrosis". Kidney International Supplements. 4 (1): 97–101. doi:10.1038/kisup.2014.18. PMC 4536960. PMID 26312158.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000064393 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000061436 – Ensembl, May 2017

expasy.org (Global: 7,021^st place; English: 7,383^rd place)

web.expasy.org

"ExPASy - ProtParam". web.expasy.org. Retrieved 2017-11-28.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Kovács KA, Steinmann M, Halfon O, Magistretti PJ, Cardinaux JR (November 2015). "Complex regulation of CREB-binding protein by homeodomain-interacting protein kinase 2" (PDF). Cellular Signalling. 27 (11): 2252–60. doi:10.1016/j.cellsig.2015.08.001. hdl:10754/594104. PMID 26247811. Archived from the original (PDF) on 2018-07-21. Retrieved 2019-07-08.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Kim YH, Choi CY, Kim Y (October 1999). "Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1". Proceedings of the National Academy of Sciences of the United States of America. 96 (22): 12350–5. Bibcode:1999PNAS...9612350K. doi:10.1073/pnas.96.22.12350. PMC 22920. PMID 10535925.
Choi JR, Lee SY, Shin KS, Choi CY, Kang SJ (November 2017). "p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function". Scientific Reports. 7 (1): 16136. Bibcode:2017NatSR...716136C. doi:10.1038/s41598-017-16489-w. PMC 5701035. PMID 29170424.
MacLachlan TK, El-Deiry WS (July 2002). "Apoptotic threshold is lowered by p53 transactivation of caspase-6". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9492–7. Bibcode:2002PNAS...99.9492M. doi:10.1073/pnas.132241599. PMC 123168. PMID 12089322.
Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, Govoni S, D'Orazi G, Racchi M (April 2010). "Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival". PLOS ONE. 5 (4) e10171. Bibcode:2010PLoSO...510171L. doi:10.1371/journal.pone.0010171. PMC 2854690. PMID 20418953.

ist.ac.at (Global: low place; English: low place)

repository.ist.ac.at

Kovács KA, Steinmann M, Halfon O, Magistretti PJ, Cardinaux JR (November 2015). "Complex regulation of CREB-binding protein by homeodomain-interacting protein kinase 2" (PDF). Cellular Signalling. 27 (11): 2252–60. doi:10.1016/j.cellsig.2015.08.001. hdl:10754/594104. PMID 26247811. Archived from the original (PDF) on 2018-07-21. Retrieved 2019-07-08.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, Debatin K, Hug H (March 2001). "Isolation and characterization of cDNAs for the protein kinase HIPK2". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1518 (1–2): 168–72. doi:10.1016/S0167-4781(00)00308-0. PMID 11267674.
Sung KS, Go YY, Ahn JH, Kim YH, Kim Y, Choi CY (June 2005). "Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation". FEBS Letters. 579 (14): 3001–8. doi:10.1016/j.febslet.2005.04.053. PMID 15896780. S2CID 37551460.
Hofmann TG, Mincheva A, Lichter P, Dröge W, Schmitz ML (2000). "Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34". Biochimie. 82 (12): 1123–7. doi:10.1016/S0300-9084(00)01196-2. PMID 11120354.
Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y (October 1998). "Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors". The Journal of Biological Chemistry. 273 (40): 25875–9. doi:10.1074/jbc.273.40.25875. PMID 9748262.
Pierantoni GM, Bulfone A, Pentimalli F, Fedele M, Iuliano R, Santoro M, Chiariotti L, Ballabio A, Fusco A (January 2002). "The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues". Biochemical and Biophysical Research Communications. 290 (3): 942–7. doi:10.1006/bbrc.2001.6310. PMID 11798164.
Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, Debatin K, Hug H (2001). "Isolation and characterization of cDNAs for the protein kinase HIPK2". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1518 (1–2): 168–72. doi:10.1016/S0167-4781(00)00308-0. PMID 11267674. The nucleotide sequence data have been deposited in GenBank under the accession numbers AF208291 and AF208292, respectively
Kim YH, Choi CY, Kim Y (October 1999). "Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1". Proceedings of the National Academy of Sciences of the United States of America. 96 (22): 12350–5. Bibcode:1999PNAS...9612350K. doi:10.1073/pnas.96.22.12350. PMC 22920. PMID 10535925.
Sung KS, Lee YA, Kim ET, Lee SR, Ahn JH, Choi CY (April 2011). "Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53". Experimental Cell Research. 317 (7): 1060–70. doi:10.1016/j.yexcr.2010.12.016. PMID 21192925.
Sombroek D, Hofmann TG (February 2009). "How cells switch HIPK2 on and off". Cell Death and Differentiation. 16 (2): 187–94. doi:10.1038/cdd.2008.154. PMID 18974774.
Zhang D, Li K, Erickson-Miller CL, Weiss M, Wojchowski DM (January 2005). "DYRK gene structure and erythroid-restricted features of DYRK3 gene expression". Genomics. 85 (1): 117–30. doi:10.1016/j.ygeno.2004.08.021. PMID 15607427.
He Q, Shi J, Sun H, An J, Huang Y, Sheikh MS (2010). "Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family". Molecular and Cellular Pharmacology. 2 (2): 61–68. PMC 2876313. PMID 20508833.
Feng Y, Zhou L, Sun X, Li Q (March 2017). "Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies". Oncotarget. 8 (12): 20452–20461. doi:10.18632/oncotarget.14723. PMC 5386776. PMID 28107201.
Kuwano Y, Nishida K, Akaike Y, Kurokawa K, Nishikawa T, Masuda K, Rokutan K (September 2016). "Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome". International Journal of Molecular Sciences. 17 (10): 1638. doi:10.3390/ijms17101638. PMC 5085671. PMID 27689990.
de la Vega L, Fröbius K, Moreno R, Calzado MA, Geng H, Schmitz ML (February 2011). "Control of nuclear HIPK2 localization and function by a SUMO interaction motif". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813 (2): 283–97. doi:10.1016/j.bbamcr.2010.11.022. PMID 21145359.
Kim EJ, Park JS, Um SJ (August 2002). "Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo". The Journal of Biological Chemistry. 277 (35): 32020–8. doi:10.1074/jbc.M200153200. PMID 11925430.
Puca R, Nardinocchi L, Givol D, D'Orazi G (August 2010). "Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells". Oncogene. 29 (31): 4378–87. doi:10.1038/onc.2010.183. PMID 20514025.
Puca R, Nardinocchi L, Bossi G, Sacchi A, Rechavi G, Givol D, D'Orazi G (January 2009). "Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc". Experimental Cell Research. 315 (1): 67–75. doi:10.1016/j.yexcr.2008.10.018. PMID 18996371.
Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH (October 2003). "Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP". Cell. 115 (2): 177–86. doi:10.1016/S0092-8674(03)00802-X. PMID 14567915. S2CID 17430200.
de la Vega L, Grishina I, Moreno R, Krüger M, Braun T, Schmitz ML (May 2012). "A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress". Molecular Cell. 46 (4): 472–83. doi:10.1016/j.molcel.2012.03.003. PMID 22503103.
Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG (July 2008). "Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR". Nature Cell Biology. 10 (7): 812–24. doi:10.1038/ncb1743. PMID 18536714. S2CID 7668614.
Choi JR, Lee SY, Shin KS, Choi CY, Kang SJ (November 2017). "p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function". Scientific Reports. 7 (1): 16136. Bibcode:2017NatSR...716136C. doi:10.1038/s41598-017-16489-w. PMC 5701035. PMID 29170424.
Wook Choi D, Yong Choi C (2014-10-29). "HIPK2 modification code for cell death and survival". Molecular & Cellular Oncology. 1 (2) e955999. doi:10.1080/23723548.2014.955999. PMC 4905192. PMID 27308327.
Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S (March 2007). "MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis". Molecular Cell. 25 (5): 739–50. doi:10.1016/j.molcel.2007.02.008. PMID 17349959.
MacLachlan TK, El-Deiry WS (July 2002). "Apoptotic threshold is lowered by p53 transactivation of caspase-6". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9492–7. Bibcode:2002PNAS...99.9492M. doi:10.1073/pnas.132241599. PMC 123168. PMID 12089322.
Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, Aikawa Y, Kimura A, Kitabayashi I (November 2007). "Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription". Oncogene. 26 (51): 7231–9. doi:10.1038/sj.onc.1210523. PMID 17533375.
Kovács KA, Steinmann M, Halfon O, Magistretti PJ, Cardinaux JR (November 2015). "Complex regulation of CREB-binding protein by homeodomain-interacting protein kinase 2" (PDF). Cellular Signalling. 27 (11): 2252–60. doi:10.1016/j.cellsig.2015.08.001. hdl:10754/594104. PMID 26247811. Archived from the original (PDF) on 2018-07-21. Retrieved 2019-07-08.
Harada J, Kokura K, Kanei-Ishii C, Nomura T, Khan MM, Kim Y, Ishii S (October 2003). "Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation". The Journal of Biological Chemistry. 278 (40): 38998–9005. doi:10.1074/jbc.M307112200. PMID 12874272.
Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, Dusetti NJ (September 2003). "TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity". The Journal of Biological Chemistry. 278 (39): 37722–9. doi:10.1074/jbc.M301979200. PMID 12851404.
Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, Govoni S, D'Orazi G, Racchi M (April 2010). "Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival". PLOS ONE. 5 (4) e10171. Bibcode:2010PLoSO...510171L. doi:10.1371/journal.pone.0010171. PMC 2854690. PMID 20418953.
Fan Y, Wang N, Chuang P, He JC (November 2014). "Role of HIPK2 in kidney fibrosis". Kidney International Supplements. 4 (1): 97–101. doi:10.1038/kisup.2014.18. PMC 4536960. PMID 26312158.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"HIPK2 homeodomain interacting protein kinase 2 [Canis lupus familiaris (dog)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-11-29.
"HIPK2 homeodomain interacting protein kinase 2 [Felis catus (domestic cat)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-11-29.
"HIPK2 homeodomain interacting protein kinase 2 [Ovis aries (sheep)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-11-29.
"hipk2 homeodomain interacting protein kinase 2 [Danio rerio (zebrafish)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-11-29.
Kim YH, Choi CY, Kim Y (October 1999). "Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1". Proceedings of the National Academy of Sciences of the United States of America. 96 (22): 12350–5. Bibcode:1999PNAS...9612350K. doi:10.1073/pnas.96.22.12350. PMC 22920. PMID 10535925.
Thierry-Mieg, Danielle; Thierry-Mieg, Jean. "AceView: Gene:HIPK2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView". www.ncbi.nlm.nih.gov. Retrieved 2017-11-28.
He Q, Shi J, Sun H, An J, Huang Y, Sheikh MS (2010). "Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family". Molecular and Cellular Pharmacology. 2 (2): 61–68. PMC 2876313. PMID 20508833.
Feng Y, Zhou L, Sun X, Li Q (March 2017). "Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies". Oncotarget. 8 (12): 20452–20461. doi:10.18632/oncotarget.14723. PMC 5386776. PMID 28107201.
Kuwano Y, Nishida K, Akaike Y, Kurokawa K, Nishikawa T, Masuda K, Rokutan K (September 2016). "Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome". International Journal of Molecular Sciences. 17 (10): 1638. doi:10.3390/ijms17101638. PMC 5085671. PMID 27689990.
Choi JR, Lee SY, Shin KS, Choi CY, Kang SJ (November 2017). "p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function". Scientific Reports. 7 (1): 16136. Bibcode:2017NatSR...716136C. doi:10.1038/s41598-017-16489-w. PMC 5701035. PMID 29170424.
Wook Choi D, Yong Choi C (2014-10-29). "HIPK2 modification code for cell death and survival". Molecular & Cellular Oncology. 1 (2) e955999. doi:10.1080/23723548.2014.955999. PMC 4905192. PMID 27308327.
MacLachlan TK, El-Deiry WS (July 2002). "Apoptotic threshold is lowered by p53 transactivation of caspase-6". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9492–7. Bibcode:2002PNAS...99.9492M. doi:10.1073/pnas.132241599. PMC 123168. PMID 12089322.
Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, Govoni S, D'Orazi G, Racchi M (April 2010). "Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival". PLOS ONE. 5 (4) e10171. Bibcode:2010PLoSO...510171L. doi:10.1371/journal.pone.0010171. PMC 2854690. PMID 20418953.
Fan Y, Wang N, Chuang P, He JC (November 2014). "Role of HIPK2 in kidney fibrosis". Kidney International Supplements. 4 (1): 97–101. doi:10.1038/kisup.2014.18. PMC 4536960. PMID 26312158.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Sung KS, Go YY, Ahn JH, Kim YH, Kim Y, Choi CY (June 2005). "Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation". FEBS Letters. 579 (14): 3001–8. doi:10.1016/j.febslet.2005.04.053. PMID 15896780. S2CID 37551460.
Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH (October 2003). "Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP". Cell. 115 (2): 177–86. doi:10.1016/S0092-8674(03)00802-X. PMID 14567915. S2CID 17430200.
Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG (July 2008). "Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR". Nature Cell Biology. 10 (7): 812–24. doi:10.1038/ncb1743. PMID 18536714. S2CID 7668614.

uniprot.org (Global: 5,673^rd place; English: 6,418^th place)

"HIPK2 - Homeodomain-interacting protein kinase 2 - Homo sapiens (Human) - HIPK2 gene & protein". www.uniprot.org. Retrieved 2017-11-28.

web.archive.org (Global: 1^st place; English: 1^st place)

Kovács KA, Steinmann M, Halfon O, Magistretti PJ, Cardinaux JR (November 2015). "Complex regulation of CREB-binding protein by homeodomain-interacting protein kinase 2" (PDF). Cellular Signalling. 27 (11): 2252–60. doi:10.1016/j.cellsig.2015.08.001. hdl:10754/594104. PMID 26247811. Archived from the original (PDF) on 2018-07-21. Retrieved 2019-07-08.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Guo Y, Sui J, Zhang Q, Barnett J, Force T, Lal H (2017-11-14). "Abstract 18728: Loss of Homeodomain-Interacting Protein Kinase 2 in Cardiomyocytes Leads to Cardiac Dysfunction". Circulation. 136 (Suppl 1): A18728. ISSN 0009-7322.

HIPK2 (English Wikipedia)

ahajournals.org (Global: 3,608th place; English: 6,526th place)

circ.ahajournals.org

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)